$XOMA Announces Closing of Tender Offer and Completed Acquisition of $GBIO
https://www.globenewswire.com/news-release/2026/02/09/3234655/7281/en/XOMA-Royalty-Announces-Closing-of-Tender-Offer-and-Completed-Acquisition-of-Generation-Bio-Inc.html
GBIO will remain halted. Shareholders will receive $4.2913 and one CVR for each share held.
$GBIO GBIO
Generation Bio (GBIO) is being acquired by XOMA Royalty Corporation, and for all intents and purposes, the stock is reaching its finish line.
Tuesday, Feb 10: The stock is expected to be officially suspended and will no longer trade on the Nasdaq.
$GBIO Equity Corporate Actions Alert #2026 - 72
(UPDATED: Corrected Expiration Date) Information Regarding the Tender Offer of Generation Bio Co. (GBIO)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-72
The tender offer by XOMA Royalty Corporation to acquire all of the outstanding common stock of Generation Bio Co. (GBIO) is scheduled to expire one minute after 11:59 p.m. ET, on February 6, 2026, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on February 9, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on February 6, 2026. If the merger closes as planned, the stock will remain halted on the day of closing (February 9th) and will be suspended effective February 10, 2026.
After closing, GBIO shareholders will receive $4.2913 and one CVR for each share held.
$GBIO The setup offers potential, but only if discipline accelerates faster than complexity. Sequential improvement must start appearing across core metrics. Consistent milestones could shift perception faster than fundamentals alone. Absent confirmation, volatility is likely to persist.
